HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: September 2 – 8, 2025

By , , and on September 11, 2025
Posted In 340B

Find this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: HRSA Audit Process; Contract Pharmacy; Other

  • In three cases challenging the Health Resources and Services Administration’s (HRSA) audit process, the plaintiff-appellants filed a motion to stay the lower court’s order granting the government’s motion to dismiss pending appeal.
  • In two cases challenging a Nebraska law governing contract pharmacy arrangements, defendants filed a brief in opposition to the amended complaint.
  • In one case challenging a Missouri law governing contract pharmacy arrangements, defendants filed a motion to dismiss the plaintiff’s first amended complaint, proposed intervenors filed a motion to intervene, and intervenors filed a brief in support of their motion to dismiss plaintiff’s first amended complaint.
  • In a case challenging an Arkansas state law governing contract pharmacy arrangements, the drug manufacturer filed a brief in support of its motion for summary judgment.
  • In a case by a covered entity against an insurance company alleging breach of contract, the court denied in part and granted in part the insurance company’s motion to dismiss.
Emily Jane Cook
Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice here.


Reuben Bank
Reuben Bank provides regulatory and transactional counseling on all aspects of state and federal healthcare laws impacting hospitals and healthcare systems.Learn more about Reuben's practice here.


Matthew David
Matthew David focuses his practice on transactional and regulatory matters affecting a wide range of clients in the healthcare industry.Learn more about Matthew's practice here.


Deepika Raj
Deepika Raj advises a broad range of healthcare industry clients on regulatory, compliance and transactional matters. She offers multifaceted advice on state and federal fraud and abuse statutes, licensure rules, cannabis laws and due diligence matters. Learn more about Deepika's practice here.

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm